Drug Developement/Delivery
- Emerging Antibody–siRNA Conjugates (ARC)
- siRNA Therapeutics: Current Status & Delivery System
- Oligonucleotide Drugs: Current Status and Challenges
- HER3 Targeted Therapies: Monoclonal Antibody, Bispecific Antibody & ADC
- Recent Advances In Hematology 2022: ADCs, Bispecific Antibodies, CAR-T Cells…
- 9 Potential Blockbuster Drugs to be Approved in 2022
- Emerging Multiple Myeloma Therapies: mAbs, ADCs, CAR-T Cells & Bispecific Antibodies
- 10 Potential Blockbuster Drug Approvals in 2023
- FDA Approves SYFOVRE™ – First Treatment for Geographic Atrophy
- Geographic Atrophy Treatments Under Investigation